Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial

The multi-center, randomized, open-label, phase III trial discussed in the present study was performed to compare the clinical outcomes of nedaplatin (NDP) plus paclitaxel, and carboplatin (CBP) plus paclitaxel for the treatment of epithelial ovarian cancer (EOC). In the current study, 182 patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncol Lett
Hauptverfasser: Li, Li, Zhuang, Qingqing, Cao, Zeyi, Yin, Rutie, Zhu, Yaping, Zhu, Lirong, Xie, Xing, Zhang, Youzhong, Wu, Qiang, Zheng, Jianhua, Zhou, Qi, Li, Xiaoping, Wu, Lingying, Feng, Youji, Wang, Changyu
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2018
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5796383/
https://ncbi.nlm.nih.gov/pubmed/29467885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.7761
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge